Literature DB >> 3503547

Secretion and metabolism of monomeric human calcitonin: effects of age, sex, and thyroid damage.

R D Tiegs1, J J Body, J M Barta, H Heath.   

Abstract

Some data suggest that human calcitonin (CT) secretion is lower in women than in men, decreases with age and the menopause, and is absent in thyroidectomized persons. To further explore CT secretory physiology, we have studied basal and calcium-stimulated plasma immunoreactive CT (iCT) and silica-extractable monomeric CT concentrations in 148 healthy volunteers and 33 patients with a history of thyroid damage (total or subtotal thyroidectomy, radioiodine treatment for thyrotoxicosis). Both whole-plasma iCT and extractable CT levels were lower basally and after calcium infusion in women than in men, basal levels being reduced about 50% and calcium-stimulated values about 75% from those of male subjects. There were no significant changes in basal iCT or extractable CT concentrations with age, and CT secretory capacity (CT response to calcium infusion) likewise did not change with age. Infusion of monomeric CT to constant concentration in 27 persons permitted estimates of CT metabolic clearance rates (MCRs) and secretion rates (SRs). Calculated MCRs of about 9 ml/min.kg-1 (persons aged 21-30 yr) and 6 ml/min.kg-1 (persons aged 54-70 yr) were in good agreement with published data, and did not differ between the sexes. SRs were dependent upon the assay method used to estimate basal plasma CT concentrations, being highest when whole-plasma iCT values were used. Based on estimates of plasma monomeric CT from the silica extraction procedure, the SR of CT was 59 +/- 6 (SE) ng/d.kg-1 in men, and 22 +/- 3 ng/d.kg-1 in women. Thyroid damage reduced, but did not abolish, apparent CT immunoreactivity, even in silica extracts of plasma. However, all subsets of thyroid-damaged patients had absent-to-markedly-impaired CT secretion in response to calcium infusion. We conclude that CT secretion is substantially lower both basally and after stimulation in women than in men, and that this difference in CT immunoreactivity probably reflects differences in circulating CT bioactivity. The sex difference in plasma CT concentrations probably results from lower rates of CT secretion in women, not increased MCR. There is no age-related decrease of plasma CT concentrations (or CT secretory reserve), calling into question the concept that a progressive deficiency of CT is partly responsible for age-related ("senile") osteoporosis. Surgical or radiation damage to the thyroid gland commonly abolishes C-cell response to calcium; such CT-deficient patients form a population suitable for determining whether or not reduced CT secretion can impair skeletal homeostasis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3503547     DOI: 10.1002/jbmr.5650010407

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  11 in total

Review 1.  Role of oestrogen in the development of osteoporosis.

Authors:  T C Hillard; J C Stevenson
Journal:  Calcif Tissue Int       Date:  1991       Impact factor: 4.333

2.  Calcitonin secretion rate in elderly normal subjects.

Authors:  M Pedrazzoni; G Ciotti; L Davoli; G Pioli; G Girasole; T Santini; M Michelini; P P Vescovi; M Passeri
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

3.  Calcitonin reserve in healthy women and patients with postmenopausal osteoporosis.

Authors:  R Pérez Cano; M J Montoya; R Moruno; A Vazquez; F Galan; M Garrido
Journal:  Calcif Tissue Int       Date:  1989-10       Impact factor: 4.333

4.  Calcitonin metabolism in senile (type II) osteoporosis.

Authors:  J Y Reginster; R Deroisy; M Bruwier; P Franchimont
Journal:  Osteoporos Int       Date:  1992-05       Impact factor: 4.507

5.  Presence or severity of Hashimoto's thyroiditis does not influence basal calcitonin levels: observations from CROHT biobank.

Authors:  M Cvek; A Punda; M Brekalo; M Plosnić; A Barić; D Kaličanin; L Brčić; M Vuletić; I Gunjača; V Torlak Lovrić; V Škrabić; V Boraska Perica
Journal:  J Endocrinol Invest       Date:  2021-10-06       Impact factor: 4.256

6.  The effect of long- and short-term corticosteroids on plasma calcitonin and parathyroid hormone levels.

Authors:  A T Hattersley; K Meeran; J Burrin; P Hill; R Shiner; H K Ibbertson
Journal:  Calcif Tissue Int       Date:  1994-03       Impact factor: 4.333

7.  Relationship between whole plasma calcitonin levels, calcitonin secretory capacity, and plasma levels of estrone in healthy women and postmenopausal osteoporotics.

Authors:  J Y Reginster; R Deroisy; A Albert; D Denis; M P Lecart; J Collette; P Franchimont
Journal:  J Clin Invest       Date:  1989-03       Impact factor: 14.808

8.  Calcitonin secretion in children with insulin-dependent diabetes mellitus.

Authors:  G Saggese; S Bertelloni; G I Baroncelli; P Ghirri
Journal:  Eur J Pediatr       Date:  1991-05       Impact factor: 3.183

9.  Meal-stimulated gastrin release and calcitonin secretion.

Authors:  M Pedrazzoni; G Ciotti; L Davoli; G Pioli; G Girasole; E Palummeri; M Passeri
Journal:  J Endocrinol Invest       Date:  1989-06       Impact factor: 4.256

10.  Calcitonin, the forgotten hormone: does it deserve to be forgotten?

Authors:  Arnold J Felsenfeld; Barton S Levine
Journal:  Clin Kidney J       Date:  2015-03-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.